EUVIMEDEUVIMED entdecken
Crossref

ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis

Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Hidenori Toyoda, Koichi Takaguchi, Makoto Nakamuta, Tsunamasa Watanabe, Asahiro Morishita, Joji Tani, Hironao Okubo, Atsushi Hiraoka, Akito Nozaki und 24 weitere

Journal of Gastroenterology · 2024

DOI: 10.1007/s00535-024-02109-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Masanori Atsukawa und 35 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo, Japan. momogac…. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Liver Cirrhosis, Antiviral Agents, Sustained Virologic Response. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This study aimed to clarify the morphological changes in esophageal varices after achieving sustained virological response (SVR) with direct-acting antivirals (DAAs) in patients with cirrhosis. METHODS: A total of 243 patients underwent esophagogastroduodenoscopy before DAA treatment and after achieving SVR. Morphological changes in esophageal varices were investigated using esophagogastroduodenoscopy. RESULTS: This study comprised 125 males and 118 females with a median age of 68 years. Esophageal varices at baseline were classified into no varix in 155 (63.8%), F1 in 59 (24.3%), F2 in 25 (10.3%) and F3 in 4 (1.6%) patients. The improvement, unchanged, and aggravation rates of esophageal varices after SVR were 11.9%, 73.3%, and 14.8%, respectively. High ALBI score at SVR12 was an independent factor associated with post-SVR esophageal varices aggravation (p = 0.045). Time-dependent receiver operating characteristic (ROC) curve analysis revealed a cut-off value of - 2.33 for ALBI score at SVR12 in predicting post-SVR esophageal varices aggravation. Of the 155 patients without esophageal varices at baseline, 17 developed de novo post-SVR esophageal varices. High ALBI score at SVR12 was a significant independent factor associated with de novo post-SVR esophageal varices (p = 0.046). ROC curve analysis revealed a cut-off value of - 2.65 for ALBI score at SVR12 in predicting de novo post-SVR esophageal varices. CONCLUSIONS: Patients with cirrhosis can experience esophageal varices aggravation or de novo esophageal varices, despite achieving SVR. In particular, patients with high ALBI score at SVR12 have a high likelihood of developing post-SVR esophageal varices aggravation or de novo post-SVR esophageal varices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal and Gastric VaricesLiver CirrhosisAntiviral AgentsSustained Virologic ResponseEndoscopy, Digestive SystemHumansMaleFemaleAgedMiddle AgedRetrospective StudiesHepatitis C, ChronicSeverity of Illness IndexAged, 80 and overROC Curve

Stichwörter der Autor:innen

Direct-acting antiviralsEsophageal varicesSustained virological response

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo, Japan. momogachi@yahoo.co.jp.
  • Project Research Units (PRU) Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo, Japan.
  • Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan.
  • Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
  • National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

Zitieren

APA

Atsukawa, M., Tsubota, A., Kondo, C., Toyoda, H., Takaguchi, K., Nakamuta, M., Watanabe, T., Morishita, A., Tani, J., Okubo, H., Hiraoka, A., Nozaki, A., Chuma, M., Kawata, K., Uojima, H., Ogawa, C., Asano, T., Mikami, S., Kato, K., …, & Iwakiri, K. (2024). ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02109-8

Vancouver

Atsukawa M, Tsubota A, Kondo C, Toyoda H, Takaguchi K, Nakamuta M, et al. ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis. Journal of Gastroenterology. 2024. doi:10.1007/s00535-024-02109-8

BibTeX
@article{Atsukawa2024,
  author = {Atsukawa, Masanori and Tsubota, Akihito and Kondo, Chisa and Toyoda, Hidenori and Takaguchi, Koichi and Nakamuta, Makoto and Watanabe, Tsunamasa and Morishita, Asahiro and Tani, Joji and Okubo, Hironao and Hiraoka, Atsushi and Nozaki, Akito and Chuma, Makoto and Kawata, Kazuhito and Uojima, Haruki and Ogawa, Chikara and Asano, Toru and Mikami, Shigeru and Kato, Keizo and Matsuura, Kentaro and Ikegami, Tadashi and Ishikawa, Toru and Tsuji, Kunihiko and Tada, Toshifumi and Tsutsui, Akemi and Senoh, Tomonori and Kitamura, Michika and Okubo, Tomomi and Arai, Taeang and Kohjima, Motoyuki and Morita, Kiyoshi and Akahane, Takehiro and Nishikawa, Hiroki and Iwasa, Motoh and Tanaka, Yasuhito and Iwakiri, Katsuhiko},
  title = {ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosis},
  journal = {Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s00535-024-02109-8}
}
Kostenlos starten →